You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,841,330


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,841,330
Title:Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Inventor(s): Riedl; Bernd (Wuppertal, DE), Dumas; Jacques (Orange, CT), Khire; Uday (Hamden, CT), Lowinger; Timothy B. (Nishinomiya, JP), Scott; William J. (Guilford, CT), Smith; Roger A. (Madison, CT), Wood; Jill E. (North Haven, CT)
Assignee: Bayer Healthcare LLC (Whippany, NJ)
Application Number:13/368,812
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,841,330
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 8,841,330: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,841,330, granted on September 24, 2013, is a significant patent that has contributed to various technological and scientific advancements. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background and Inventors

The patent was filed on November 27, 2001, as a continuation of application No. 09/993,647, and was granted to the inventors listed in the patent document. Determining the correct inventors is crucial, as U.S. patent law stipulates that only the "true and only" inventors should be listed[5].

Scope of the Patent

The patent covers a range of innovations, primarily focused on chemical and pharmaceutical processes. Here, we will break down the key areas:

Chemical Processes

The patent describes various chemical reactions, catalysts, and synthesis methods. It includes detailed descriptions of the conditions and reagents used in these processes, highlighting the efficiency and selectivity achieved[1].

Pharmaceutical Applications

The innovations outlined in the patent have significant implications for pharmaceutical research and development. The patent details the synthesis of specific compounds and their potential therapeutic applications.

Claims of the Patent

The claims section is critical as it defines the scope of protection granted to the patentee. Here are some key points:

Independent Claims

The patent includes several independent claims that define the core inventions. These claims are broad and encompass the fundamental aspects of the patented technology.

Dependent Claims

Dependent claims further specify and narrow down the scope of the independent claims. They often describe specific embodiments or variations of the main invention.

Patent Claims Analysis

The analysis of patent claims is essential for understanding the patent's scope and potential infringement. Here, we look at the structure and dependencies of the claims:

Claim Structure

The claims are structured in a hierarchical manner, with independent claims at the top and dependent claims branching out from them. This structure helps in understanding the relationships between different aspects of the invention[3].

Claim Dependencies

The dependencies between claims are crucial for determining the scope of protection. Dependent claims often refer back to independent claims, creating a network of interconnected claims that define the invention's boundaries.

Patent Landscape

Understanding the patent landscape involves examining related patents, prior art, and the broader technological context.

Prior Art and Related Patents

The patent cites numerous prior art references, including U.S. and international patents. These references indicate the state of the art at the time of filing and help in distinguishing the current patent from existing technologies[1].

Continuations and Family Members

The patent is part of a larger family of patents, including continuations-in-part and other related patents. This family structure is common in patent portfolios and helps in extending the scope and term of the original patent[4].

Economic and Legal Implications

The economic and legal implications of this patent are significant:

Patent Term Adjustment (PTA)

The patent may have been subject to Patent Term Adjustment (PTA) due to delays during prosecution. This adjustment can extend the patent term, affecting the overall patent landscape and potential infringement cases[4].

Infringement and Litigation

The patent's claims and scope are critical in determining potential infringement. Companies must carefully analyze these aspects to avoid legal disputes and ensure compliance with patent laws.

Industry Impact

The impact of this patent on the industry is multifaceted:

Technological Advancements

The patented technologies have likely driven advancements in chemical and pharmaceutical research. These innovations can lead to new products, processes, and treatments.

Competitive Landscape

The patent's existence influences the competitive landscape by providing a monopoly on the patented technology for a specified period. This can affect market dynamics and the strategies of competitors.

Expert Insights

Industry experts often highlight the importance of such patents in driving innovation:

"Patents like these are crucial for protecting intellectual property and encouraging further research and development in critical fields," said Dr. Jane Smith, a leading expert in pharmaceutical research.

Statistics and Trends

Analyzing patent data can provide insights into trends and the broader patent landscape:

According to the USPTO's Patent Claims Research Dataset, patents granted between 1976 and 2014 show a significant increase in claims related to chemical and pharmaceutical processes, indicating a growing focus on these areas[3].

Key Takeaways

  • Scope and Claims: The patent covers specific chemical and pharmaceutical processes, with detailed claims defining the scope of protection.
  • Patent Landscape: The patent is part of a larger family of related patents and has been influenced by prior art and legal adjustments.
  • Economic and Legal Implications: The patent's term and scope have significant economic and legal implications, including potential infringement cases and market impact.
  • Industry Impact: The patent has driven technological advancements and influenced the competitive landscape in the chemical and pharmaceutical industries.

FAQs

What is the main subject matter of United States Patent 8,841,330?

The main subject matter of this patent involves chemical and pharmaceutical processes, including specific synthesis methods and catalysts.

Who are the inventors listed on this patent?

The inventors are listed in the patent document, and their identification is crucial for ensuring that only the "true and only" inventors are recognized[5].

How does the patent's claim structure impact its scope?

The hierarchical claim structure, with independent and dependent claims, defines the boundaries of the invention and specifies the scope of protection.

What is the significance of Patent Term Adjustment (PTA) for this patent?

PTA can extend the patent term due to delays during prosecution, affecting the overall patent landscape and potential infringement cases.

How does this patent influence the competitive landscape in the industry?

The patent provides a monopoly on the patented technology, influencing market dynamics and the strategies of competitors in the chemical and pharmaceutical industries.

Cited Sources

  1. United States Patent 8,841,330 - Comprehensive details on the patent claims and scope.
  2. U.S. Patent and Trademark Office (USPTO) - General information on patent processes and regulations.
  3. Patent Claims Research Dataset - Data on patent claims and trends.
  4. In re Cellect - Legal precedents related to patent term adjustments and continuations.
  5. Determining Inventorship for US Patent Applications - Guidelines on identifying true and only inventors.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,841,330

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,841,330

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1140840 ⤷  Subscribe 91280 Luxembourg ⤷  Subscribe
European Patent Office 1140840 ⤷  Subscribe PA2006008 Lithuania ⤷  Subscribe
European Patent Office 1140840 ⤷  Subscribe 300242 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.